Prospective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery

ISRCTN ISRCTN14478115
DOI https://doi.org/10.1186/ISRCTN14478115
Secondary identifying numbers 03-274
Submission date
29/07/2004
Registration date
21/09/2004
Last edited
07/03/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr David Royston
Scientific

Department of Anaesthesia
Harefield Hospital
Hill End Road
Harefield
UB9 6JH
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Scientific titleProspective blinded randomised placebo controlled trial investigating whether oxycodone modified release reduces parenteral opioid use following intermediate thoracic surgery
Study acronymOxyPATS
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPost-operative pain following intermediate thoracic surgery
InterventionOxycodone modified release 10 mg bd or placebo for 48 hrs postoperatively.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Oxycodone
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2004
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration
Key inclusion criteriaAdult patients scheduled for unilateral intermediate thoracic surgery (e.g. pleural abrasion, talc pleurodesis and lung biopsy)
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2004
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Anaesthesia
Harefield
UB9 6JH
United Kingdom

Sponsor information

Harefield Hospital (UK)
Hospital/treatment centre

Dr CPR Walker
Department of Anaesthesia & Pain Management
Hill End Road
Harefield
UB9 6JH
England
United Kingdom

ROR logo "ROR" https://ror.org/04fwa4t58

Funders

Funder type

Industry

Royal Brompton & Harefield NHS Trust fund the salaries.

No information available

Napp Pharmaceuticals are supplying the study drugs and placebos.

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

07/03/2017: No publications found in PubMed, verifying study status with principal investigator